Ume Nishar Banu S., Abhishek Mondal, Abhishek K., Samhitha J., Shivalinge Gowda K. P.*, Shanaz Tejani- Butt, Nataraj Loganayaki, Khader Shareef K. S. and Venkateswarlu K.


Aim: The present study evaluated the activity of Digesti’Vas on gastrointestinal motility, appetite and hepatoprotective effects in a rodent model. Methods: Digesti’Vas is a polyherbal formulation developed by Suguna Foods Pvt Ltd. Acute toxicity and gastrointestinal motility activity were evaluated in mice. Appetite activity and potential hepatoprotective effects were evaluated in rats. Results: Since Digesti’ Vas did not exhibit acute toxicity when given orally up toa concentration of 2000 mg/kg bw, 200mg/kg body wt(1/10th of 2000 mg/kg) was selected as the median dose. Digesti’Vas showed a significant increase in mean defecation period (346.2 ± 65.83min), comparable to the positive control, loperamide (383.0 ± 37.83min), in comparison to the normal control group (251.2 ± 60.32min). Digesti’Vas treatment also led to a significant increase in the percentage change in body weight (8.367±3.021 g) when compared to the normal control group (3.618±2.088g) and a significant increase in percentage change in food intake (13.28±3.673 g) when compared to the normal control group (8.657±2.160 g). When measurements were done on various liver parameters, it was found that Digesti’Vas treated animals showed a significant decrease in serum ALP levels (401.8±10.04U/L) compared to CCl4 treated animals (493.2±108.4 U/L); comparable to the positive control, Silymarin (370.5±37.82 U/L). Digesti’Vas significantly decreased serum SGPT levels (57.03±66.01U/L), compared to CCl4 treated animals (420.8±214.1 U/L); in agreement with levels seen in Silymarin treated animals (61.39±37.87 U/L).Furthermore, Digesti’Vas significantly decreased SGOT (6.953±3.712 U/L) levels compared to the CCl4 treated group (29.65±5.765 U/L), in keeping with levels seen after treatment with Silymarin (10.71±6.135 U/L). Conclusion: This study suggests that Digesti’Vas, a herbal preparation that is formulated by Suguna Foods Pvt Ltd, possesses antimotility, hepatoprotective, and increased appetite effects in a rodent model. Future studies investing the role of Digesti’Vas in alleviating gastrointestinal disorders are certainly warranted.

Keywords: Appetite, Digesti’Vas, Gastrointestinal motility, Loperamide, SGOT (Serum Glutamic-Oxaloacetic Transaminase).

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation


    SEPTEMBER 2018 Issue has been successfully launched on 1 September 2018

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 4.382 to 4.918 due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction